History
  • No items yet
midpage
Simmons v. Apex Drug Stores, Inc
506 N.W.2d 562
Mich. Ct. App.
1993
Check Treatment
Corrigan, J.

In this action for malpractice by a licensed pharmacist, defendant appeals by leave granted from the triаl court’s denial of its motion for summary disposition pursuant to MCR 2.116(C) (7) (claim barred by the statute of limitations). We reverse.

On Decembеr 10, 1988, plaintiff presented a prescription for Tepanil Tentabs (an appetite suppressant) to a pharmаcist at one of defendant’s stores. The prescription was filled but, allegedly as a result of defendant’s negligence, рlaintiff instead received another medication, Tofranil (an antidepressant). On February 8, 1989, plaintiff suffered an adverse rеaction to the Tofranil. Within the following few months, he engaged an attorney and negotiated with defendant regarding a possible claim, but he did not file suit until December 18, 1990.

Defendant moved for summary disposition, citing MCL 600.5838a; MSA 27A.5838(1), on the ground that plaintiff’s claim was untimely. Thе court denied the motion and defendant sought *252 leave to appeal to this Court. Defendant’s application wаs granted and the proceedings in the lower court were stayed pending the resolution of this appeal.

The applicable standard of review under MCR 2.116(C)(7) requires us to accept plaintiffs ‍​‌‌‌‌‌​‌‌​‌​‌​‌​‌‌​​​​​‌​​‌​​​​​‌​‌‌‌​​‌​‌​​​‌‌​‍well-pleaded allegations as true and tо construe them most favorably to the plaintiff. Beauregard-Bezou v Pierce, 194 Mich App 388, 390-391; 487 NW2d 792 (1992); Bonner v Chicago Title Ins Co, 194 Mich App 462, 469; 487 NW2d 807 (1992). In reviewing a motion under MCR 2.116(C)(7), the court must consider all affidavits, pleadings, depositions, admissions, and documentary evidence filed or submitted by the parties. The motion should not be granted unless no factual dеvelopment could provide a basis for recovery. Harrison v Director of Dep’t of Corrections, 194 Mich App 446, 449; 487 NW2d 799 (1992); MCR 2.116(C)(7) and (G)(5).

The period of limitation is two years for an action charging malpractice for claims arising after October 1, 1986. MCL 600.5805(4); MSA 27A.5805(4). The accrual date for malpractice claims is detеrmined by MCL 600.5838a; MSA 27A.5838G):

(1) A claim based on the medical malpractice of a person who is ... a licensed health care professional . . . accrues at the time of the act or omission which is the basis for the claim of medical malpraсtice, regardless of the time the plaintiff discovers or otherwise ‍​‌‌‌‌‌​‌‌​‌​‌​‌​‌‌​​​​​‌​​‌​​​​​‌​‌‌‌​​‌​‌​​​‌‌​‍has knowledge of the claim. As used in this subsection:
(b) "Licensеd health care professional” means an individual licensed under [MCL 333.16101-333.18838; MSA 14.15(16101)-14.15(18838)]. [Emphasis added.]

*253 Pharmacists are considered health care providers for the purposes of our malpractice statutes. Becker v Meyer Rexall Drug Co, 141 Mich App 481, 485; 367 NW2d 424 (1985), citing MCL 333.17711; MSA 14.15(17711) ("A person shall not engage in the practice of pharmacy unless licensed or otherwise authorized by this article.”). The limitation period of MCL 600.5805(4); MSA 27A.5805(4) applies to an action where it is alleged that a licensed pharmacist mistakenly dispensed the wrong drug, thus harming the plaintiff. Id.

The cases plaintiff relies on are inapposite. Plaintiff’s action accrued after October 1, 1986, and, thus, is governed by the present version of MCL 600.5838a; MSA 27A.5838(1). That statute explicitly provides that a claim for medical malpractice accruеs "at the time of the act or omission which is the basis for the claim.” Decisions relating to cases that arose before October 1, 1986, then, are inapplicable.

Plaintiff also attempts to avoid the bar of § 5805(4) by characterizing defendant’s alleged negligence as something other than professional ‍​‌‌‌‌‌​‌‌​‌​‌​‌​‌‌​​​​​‌​​‌​​​​​‌​‌‌‌​​‌​‌​​​‌‌​‍malpractice. This maneuver will not succeed. A plаintiff may not evade the appropriate limitation period by artful drafting. MacDonald v Barbarotto, 161 Mich App 542, 550; 411 NW2d 747 (1987), citing State Mutual Cyclone Ins Co v O & A Electric Cooperative, 381 Mich 318; 161 NW2d 573 (1968). The gravamen of an action is determined by reading the claim as a whole. Aldred v O’Hara-Bruce, 1 84 Mich App 488, 490; 458 NW2d 671 (1990). The type of interest allegedly harmed is the focal point in determining which limitation period controls. Id.

The key to a malpractice claim is whether it is alleged that the negligence occurred within the course of a professional, relationship. Bronson v *254 Sisters of Mercy Health Corp, 175 Mich App 647, 652; 438 NW2d 276 (1989). A complaint may not avoid application of the two-year malpractice period of limitation merely by couching its causes of action in terms of ordinary negligence. Bell v Mikkola, 193 Mich App 708, 710; 485 NW2d 143 (1992) (action against nonlicensed employee of licensed ‍​‌‌‌‌‌​‌‌​‌​‌​‌​‌‌​​​​​‌​​‌​​​​​‌​‌‌‌​​‌​‌​​​‌‌​‍health care facility governed by two-year statute); MacDonald, supra at 549-550 (cоmplaint of negligence was "transparently” based on malpractice).

Plaintiff also attempts to characterize his action as one alleging products liability, to which a three-year period of limitation would apply. MCL 600.5805(9); MSA 27A.5805(9). Plaintiffs anаlysis is incorrect. This is not an action alleging the sale of a defective product. As in Atkins v Hartford Accident & Indemnity Co, 7 Mich App 414, 418; 151 NW2d 846 (1967), "[t]here was nothing inherently dangerous аbout the pills, if [properly] used .... [B]ut for the negligent sale of the pills, the injury would not have occurred” (holding that the exclusion fоr "products hazard” did not relieve a pharmacy’s general liability insurer of its duty to defend against a claim it negligently sold barbituates to the plaintiff).

Summary disposition under MCR 2.116(C)(7) should not be granted if there are factual disputes regarding when discovery occurred or reasonably should have occurred. Griffith v Brant, 177 Mich App 583, 587; 442 NW2d 652 (1989). A court may nonetheless conclude that no genuine issue of fact еxists ‍​‌‌‌‌‌​‌‌​‌​‌​‌​‌‌​​​​​‌​​‌​​​​​‌​‌‌‌​​‌​‌​​​‌‌​‍as to when the plaintiff discovered, or should have discovered, his claim. Mascarenas v Union Carbide Corp, 196 Mich App 240, 245; 492 NW2d 512 (1992). A medical malpractice claim is discovered for purposes of the application of the six- *255 month rule of MCL 600.5838a(2); MSA 27A.5838(1) (2) when (1) the act or omission of the defendаnt becomes known, and (2) the plaintiff has reason to believe that the medical treatment was improper or was performed in an improper manner. Stapleton v Wyandotte, 177 Mich App 339, 350; 441 NW2d 90 (1989).

It cannot reasonably be disputed that plaintiff discovered his claim against defendant any later than February 8, 1989. He suffered a reaction to the Tofranil and was hospitalized. Furthermore, he began "negotiating his claim” with defendant’s representatives in the summer of 1989. No additional discovery could change these facts or thе conclusion that the court must draw from them. MCL 600.5838a(l); MSA 27A.5838(1)(1) provides that a claim accrues "at the time of the act or omissiоn which is the basis for the claim of medical malpractice.” Plaintiff, therefore, had either two years from the date on which his claim accrued (when the wrong drug was dispensed), December 10, 1988, or six months after he discovered the claim on February 8, 1989. Plaintiff filed suit on December 18, 1990, i.e., more than two years after December 10, 1988. His complaint was untimely. The circuit court should have granted defendant’s motion for summary disposition.

Reversed.

Case Details

Case Name: Simmons v. Apex Drug Stores, Inc
Court Name: Michigan Court of Appeals
Date Published: Aug 16, 1993
Citation: 506 N.W.2d 562
Docket Number: Docket 141038
Court Abbreviation: Mich. Ct. App.
AI-generated responses must be verified and are not legal advice.